Paxlovid decreased hospitalisation, risk of death during Omicron wave: Research
The research, published in the Canadian Medical Association Journal, aimed to evaluate the effectiveness of paxlovid, a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Paxlovid
China allows sale of Pfizer oral drug as demand surges in wake of rising COVID cases
The agreement is valid between 14th December and 30th November, 2023, China Meheco said in a filing to the Shanghai stock exchange
Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment
Hetero’s ‘NIRMACOM’ (Nirmatrelvir), a generic version of Pfizer’s COVID-19 oral antiviral drug ‘PAXLOVID’is co-packaged with…
China Meheco to distribute Pfizer’s COVID treatment in China
Pfizer signed a deal in August for Chinese drugmaker Zhejiang Huahai to produce Paxlovid in mainland China solely for patients…
US to pay Pfizer nearly $2 billion for more Paxlovid courses in 2023
The new purchase supplements the 20 million courses previously bought by the US, and are planned for delivery by early 2023
Pfizer sees $10-$15 billion in annual mRNA vaccine revenue by 2030
The company provided potential revenue details from vaccines across its portfolio, including its already-approved COVID-19 vaccine…
US government to test Pfizer’s Paxlovid for long COVID
The Duke Clinical Research Institute is supervising the study, which is scheduled to start on 1st January
Zenara Pharma launches Paxlovid generic for COVID-19 in India
The drug reduces the risk of death or hospitalisation by 89 per cent
Pfizer to spend $120 million to boost US COVID pill manufacturing
Use of the pill, Paxlovid, authorised to treat newly infected, at-risk people to prevent severe illness, has soared recently as…
WHO recommends Pfizer’s Paxlovid for wide geographical distribution
Pfizer’s oral antiviral drug (a combination of Nirmatrelvir and Ritonavir tablets) is strongly recommended for patients with…